GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend
GPT Healthcare Ltd 路 Intimation 路 05 Nov 2026, 5:30 am
GPT Healthcare Board to Consider Q2 FY26-27 Results and Interim Dividend GPT Healthcare Limited has scheduled its Board of Directors meeting on 5th Nov'26 to consider and approve the unaudited financial results alongside the statutory auditors' limited review report for Q2 and H1 ended 30th Sep'26. The board will also evaluate the declaration of an interim dividend for FY 2026-27 on the company's equity share capital. Consequently, the trading window for company securities remains closed until 7th Nov'26 in compliance with insider trading regulations.
Original exchange filing (PDF)
More announcements from GPT Healthcare Ltd
- Please find enclosed herewith Earnings Call Transcript. 路 14 Nov 2026
- Please find enclosed herewith audio call recording of Earnings call for Q2H1FY27. 路 06 Nov 2026
- Please find enclosed herewith Press Release on Un-Audited Financial Results for Q2 & H1 FY27. 路 05 Nov 2026
- Please find enclosed herewith Investor Presentation on Un-Audited Financial Results for the Q2 & H1 FY27. 路 05 Nov 2026
- Please find enclosed herewith the Un-Audited Financial Results for Q2 & H1 FY 27. 路 05 Nov 2026
- Please find the intimation of record date for Interim Dividend. 路 05 Nov 2026
- Please find enclosed intimation Board approving Interim Dividend and Record Date. 路 05 Nov 2026
- GPT Healthcare Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 05 Nov 2026
